JPS5933222A - 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 - Google Patents
合成デオキシリボ核酸を有効成分とする抗腫瘍剤Info
- Publication number
- JPS5933222A JPS5933222A JP14339882A JP14339882A JPS5933222A JP S5933222 A JPS5933222 A JP S5933222A JP 14339882 A JP14339882 A JP 14339882A JP 14339882 A JP14339882 A JP 14339882A JP S5933222 A JPS5933222 A JP S5933222A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- active ingredient
- poly
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14339882A JPS5933222A (ja) | 1982-08-20 | 1982-08-20 | 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14339882A JPS5933222A (ja) | 1982-08-20 | 1982-08-20 | 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5933222A true JPS5933222A (ja) | 1984-02-23 |
JPH0534338B2 JPH0534338B2 (enrdf_load_html_response) | 1993-05-21 |
Family
ID=15337834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14339882A Granted JPS5933222A (ja) | 1982-08-20 | 1982-08-20 | 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5933222A (enrdf_load_html_response) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018987A1 (en) * | 1993-02-19 | 1994-09-01 | Nippon Shinyaku Co., Ltd. | Drug composition containing nucleic acid copolymer |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10590384B2 (en) | 2014-01-14 | 2020-03-17 | Luterion Co., Ltd. | Luterial and method for isolating and culturing the same |
US10624926B2 (en) | 2014-01-14 | 2020-04-21 | Luterion Co., Ltd. | Luterial and method for isolating and culturing the same |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57145815A (en) * | 1981-03-04 | 1982-09-09 | Sanraku Inc | Antitumor agent |
JPS5855499A (ja) * | 1981-09-28 | 1983-04-01 | Sanraku Inc | 抗腫瘍性を有する変性デオキシリボ核酸の製法 |
-
1982
- 1982-08-20 JP JP14339882A patent/JPS5933222A/ja active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57145815A (en) * | 1981-03-04 | 1982-09-09 | Sanraku Inc | Antitumor agent |
JPS5855499A (ja) * | 1981-09-28 | 1983-04-01 | Sanraku Inc | 抗腫瘍性を有する変性デオキシリボ核酸の製法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018987A1 (en) * | 1993-02-19 | 1994-09-01 | Nippon Shinyaku Co., Ltd. | Drug composition containing nucleic acid copolymer |
Also Published As
Publication number | Publication date |
---|---|
JPH0534338B2 (enrdf_load_html_response) | 1993-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ninane et al. | Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study | |
CN116808219A (zh) | 用于治疗免疫系统功能障碍的γ分泌酶调节剂 | |
JP2020055884A (ja) | がんのためのグルフォスファミド組み合わせ療法 | |
US6063814A (en) | Phorbol esters as anti-neoplastic and white blood cell elevating agents | |
EP0350801A2 (en) | Polyprenols and polyprenyl phosphates for the inhibition of tumour metastasis | |
JPS61151123A (ja) | 安定化された3―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤 | |
JPH11322596A (ja) | 白金錯体および環状リン酸エステルアミドを含有する抗癌剤 | |
JPS6287516A (ja) | 悪性腫瘍の生体外での処置法 | |
JPS63145229A (ja) | ビタミンb6含有医薬組成物 | |
WO1998039013A1 (en) | Composition and method for treating cancer and immunological disorders resulting in chronic conditions | |
US4384001A (en) | Treatment of tumors with thiazolidine-4-carboxylic acid | |
WO2005023273A1 (en) | Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents | |
JPS5933222A (ja) | 合成デオキシリボ核酸を有効成分とする抗腫瘍剤 | |
EP4095137A1 (en) | Use of pyrido[1,2-a]pyrimidinone compound in treating lymphoma | |
JPH07116031B2 (ja) | 制癌剤 | |
CN109528731B (zh) | 具有协同作用治疗多发性骨髓瘤的药物组合物及其应用 | |
WO1992011247A1 (en) | Anticancer composition and compound | |
CN107308121A (zh) | 肝脏再生的治疗剂 | |
CN110876803B (zh) | 一种包含乳蛋白和油酸的药物组合物 | |
EP1210944A1 (en) | Blood plasma replacement solution | |
Sung et al. | Re-evaluation of 5-fluorouracil as a single agent for gestational malignant trophoblastic neoplasms | |
JPH0211513A (ja) | 制癌剤 | |
CA1319107C (en) | Formulations for inhibiting glucose transport | |
Killen et al. | Phase II studies of methyl glyoxal bis‐guanylhydrazone (NSC 32946) in carcinoma of the colon and lung | |
Giuliani et al. | Combination chemotherapy and surgical adjuvant chemotherapy on MS-2 sarcoma and lung metastases in mice |